FDA approves Abbott’s FreeStyle Libre 14-day flash glucose monitoring system
Abbott has secured approval from the US Food and Drug Administration (FDA) for its FreeStyle Libre 14-day flash…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jul 18
Abbott has secured approval from the US Food and Drug Administration (FDA) for its FreeStyle Libre 14-day flash…
18 Jul 18
CeQur has acquired select assets of Calibra Medical, one of the Johnson & Johnson Diabetes Care Companies.
06 Jul 18
Canada-based medical device company Sernova has started patient screening and recruitment critical trial for its regenerative medicine trial…
26 Jun 18
Medtronic has secured CE mark approval for its MiniMed 670G hybrid closed loop system, which is claimed to…
26 Jun 18
Valeritas’ V-Go wearable insulin delivery device helped to improve blood glucose levels and reduce insulin dose in type…
Medtronic, along with its technology partner IBM Watson Health, has announced commercially availability of artificial intelligence (AI) powered…
13 Jun 18
Johnson & Johnson (J&J) has accepted Platinum Equity’s $2.1bn acquisition offer for its diabetes business unit, LifeScan.